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Abstract
Background: Brucellosis is an endemic zoonotic disease in most of the developing world that causes devastating
losses to the livestock industry and small-scale livestock holders. Infected animals exhibit clinical signs that are of
economic significance to stakeholders and include reduced fertility, abortion, poor weight gain, lost draught power,
and a substantial decline in milk production. In humans, brucellosis typically manifests as a variety of non-specific
clinical signs. Chronicity and recurring febrile conditions, as well as devastating complications in pregnant women
are common sequelae.
Discussion: In regions where the disease is endemic, brucellosis has far-reaching and deleterious effects on humans and
animals alike. Deeply entrenched social misconceptions and fear of government intervention contribute to this disease
continuing to smolder unchecked in most of the developing world, thereby limiting economic growth and inhibiting
access to international markets. The losses in livestock productivity compromise food security and lead to shifts in the
cognitive competency of the working generation, influence the propagation of gender inequality, and cause profound
emotional suffering in farmers whose herds are affected. The acute and chronic symptoms of the disease in humans can
result in a significant loss of workdays and a decline in the socioeconomic status of infected persons and their families
from the associated loss of income. The burden of the disease to society includes significant human healthcare costs
for diagnosis and treatment, and non-healthcare costs such as public education efforts to reduce disease transmission.
Conclusion: Brucellosis places significant burdens on the human healthcare system and limits the economic growth of
individuals, communities, and nations where such development is especially important to diminish the prevalence of
poverty. The implementation of public policy focused on mitigating the socioeconomic effects of brucellosis in human
and animal populations is desperately needed. When developing a plan to mitigate the associated consequences, it is
vital to consider both the abstract and quantifiable effects. This requires an interdisciplinary and collaborative, or One
Health, approach that consists of public education, the development of an infrastructure for disease surveillance and
reporting in both veterinary and medical fields, and campaigns for control in livestock and wildlife species.
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Background
Brucellosis is a zoonotic disease that severely hinders
livestock productivity and human health worldwide. The
burden that the disease places specifically on low-income
countries has led the World Health Organization (WHO)
to classify it as one of the world’s leading ‘neglected
zoonotic diseases’ [1]. Brucellosis is caused by bacteria of
the genus Brucella, with Brucella abortus, Brucella meliten-
sis, and Brucella suis; infecting cattle, small ruminants, and
swine, respectively, being species of particular importance
in human and livestock infections worldwide. Other species
of concern include Brucella canis, infecting dogs, and
Brucella ovis, infecting sheep [2].
In animals, brucellosis is highly contagious and cross-
species transmission of certain Brucella spp. can occur
[2]. Mucosal contact with aborted fetuses and fetal
membranes, which contain large amounts of the bacteria,
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is an important means of transmission in livestock [3].
Infected livestock exhibit clinical signs of great economic
significance to stakeholders (i.e., small scale livestock
farmers, meat and milk industry, human communities,
etc.), including reduced fertility, abortion, and a substan-
tial decline in milk production over an animal’s lifespan
[4]. In humans, brucellosis typically manifests as a range
of non-specific clinical signs including malaise, fatigue,
arthritis, and fever. Chronicity and recurring febrile condi-
tions with joint pain are common sequelae [5]. The acute
and chronic symptoms of the disease can result in a
significant loss of work days and consequential disparity
in the socioeconomic status of infected persons and their
families. Human-to-human transmission can occur trans-
placentally, via breastfeeding, and rarely through sexual
intercourse, organ transplantation and blood transfusions
[6]. Transmission can also occur through direct contact
with infected animals, their tissues (e.g. placenta or
aborted tissues), or their products (e.g. dairy) [5]. While
pasteurizing milk is an effective means to kill Brucella and
prevent infection in humans, this precaution is not
routinely practiced in some resource limited communities
because of long- standing cultural practices and a general-
ized lack of understanding by the public about the dangers
of consuming raw milk [7]. In Egypt, for example, social
misconceptions about the nutritive quality of pasteurized
milk has led to a reduction in consumption of commercial
milk products, leaving raw milk from small-scale dairy
producers to account for up to 80% of the total milk in-
dustry (up to 4 billion liters per year), according to the
chairman of the Egyptian Chamber of Food Industries [8].
Exacerbating the problem are the food products from
informal markets that predominate in low and middle
income countries and often escape meeting the appropri-
ate health and safety standards before reaching the
consumer [9].
In low and middle-income countries, misconceptions
about Brucella’s true incidence often arise from underre-
porting and insufficient monitoring data, a lack of financial
resources and capacity, and efforts between veterinarians
and human medics. All contribute to the continued
prevalence of brucellosis [10]. Paired with the presence of
rampant social stigmas and mistrust regarding government
intervention, this has allowed Brucella to increase unchal-
lenged in the marginalized human and animal populations
of the world. For example, in India, religious beliefs
denounce practices that include the test and slaughter of
livestock for infectious diseases, and small scale livestock
keepers have been known to avoid diagnostics for fear of
consequences (e.g., slaughter of their entire herd) if a single
animal were to test positive for brucellosis [9, 11]. Zinsstag
et al., 2006 [12] discusses nomadic pastoralists who live in
many areas of the world and their vulnerability to brucel-
losis because of close contact during animal husbandry and
consumption of livestock products. He further discusses
that though they are socially marginalized, they make
significant contributions to national gross domestic prod-
ucts (GDPs) by making marginal lands more productive.
This paper aims to synthesize both the well and poorly
understood factors that account for the wide-ranging
socioeconomic impact of brucellosis in regions of the
world where it is endemic. We address dimensions of
the Brucella discussion that have to date been neglected,
largely because their abstract nature makes them
difficult to assess quantitatively. We also aimed at assist-
ing researchers in their prioritization and decision-
making processes by comprehensively assessing the
complexities associated with reducing the global impact
of brucellosis. To accomplish this, we used economic
frameworks, published by Rushton et al. 1999 [13], and
Jo in 2014 [14], to explore the impact that brucellosis
has in regions of the world where it currently exists. Fol-
lowing this, we offer an assessment of the collaboration
required to address this issue, along with a call for ac-
tion; that is developing a One Health approach through
the collaboration of human, animal and public healths
to demonstrate an added value of cost savings and/or
improved health by working in concert rather than
alone.
Discussion
Worldwide distribution of brucellosis
We use published case studies and reviews to highlight
the estimated prevalence of brucellosis in regions where
it is endemic. However, it should be noted that because
many areas with endemic brucellosis have poor medical
and veterinary infrastructures, the true incidence of
disease is likely to be markedly under-reported [15].
Middle East
A review paper published by Musallam et al., 2015 [16]
compiled the available prevalence data sets for the
region of the Middle East and screened them for quality
of reporting. The screening process included reviewing
retrieved abstracts by the primary author based on the
following inclusion of four criteria. First, the research
was original and studied a human or animal population
in a Middle Eastern country; second, the article was
published in a peer-reviewed section of a journal; and,
third, that the research was written in Arabic, English,
French or Persian. The fourth criterion was to determine
if the research provided estimates of the frequency of
Brucella spp. infection in domestic ruminants and/or
humans, or estimates of the strength of the association
between Brucella spp. (sero)-positivity in humans and
potential risk factors. If required for clarification, the full
text was retrieved and the article subjected to quality
assessment and data extraction. Per their data, B. melitensis
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and B. abortus have been confirmed in most countries of
the Middle East [16]. The seroprevalence results from small
ruminant populations in these regions is remarkable. For
example, studies from Egypt in 2008 suggest a brucellosis
true seroprevalence rate of: 12.2% prevalence in sheep,
11.3% prevalence in goats, 41.3% true prevalence of sheep
and 32.2% of goats in infected villages [17]. Published data
from other countries in the Middle East reinforce that bru-
cellosis is a significant problem in the region. In Saudi Ara-
bia, for example, consumption of raw milk by people
resulted in a 3.0 to 3.8 times greater probability that an in-
dividual would be seropositive for Brucella antibodies on
serology [18]. This is consistent with reports from Jordan,
where sheep seroprevalence of brucellosis was estimated to
be 2.2% at the individual animal level and 45% at the herd
level [19].
Africa and Asia
In 2013, a study by McDermott et al. [4] was conducted
to estimate the economic impact of brucellosis in the
developing nations of Africa and South/ Southeast Asia.
In all, 259 studies on brucellosis from these regions were
analyzed and encompassed observations from 500,000
animals, 30,000 people, and 600 food samples. While the
sensitivity and specificity of surveillance and diagnostic
tests can over- or underestimate the true prevalence of
disease, the compiled information from this work
provides a valuable estimate. The data revealed an
average prevalence range of 0–88.8% in sheep and goats,
0–68.8% in cattle, 0.4–20% in camels, and 0–12.9% in
other species (pigs and dogs). In high risk human
populations, such as veterinarians, livestock handlers,
and abattoir workers, the average prevalence was 11%.
Among hospital patients in which brucellosis was
consistent with the clinical picture, the prevalence was
7% [4]. These data suggest that brucellosis is endemic
across the African and Asian continents and is a major
cause of disease in humans and livestock [4].
Central and South America
A retrospective analysis of brucellosis in Latin America
was published by Lucero et al. in 2008 [20]. Overall, the
study reports that in Latin American countries, the
prevalence of brucellosis in cattle ranges from 0.5% -
10%. However, the prevalence of the disease in suids is
currently unknown. There is also a lack of significant
data about Brucella in small ruminants from the region.
In Argentina, official data reports note that the
estimated prevalence of brucellosis in cattle is 10–15%
among herds and 4–5% among individual animals, the
species also composing the largest sector of the livestock
industry [20]. In Central America, B. abortus and B. suis
have been identified in every country and B. melitensis
in Guatemala, with the prevalence rate of brucellosis
in Central American cattle estimated to be between 4
and 8% [21].
Overview of brucellosis impact in livestock where it is
endemic
In this section, we adapt the framework proposed by
Rushton et al. 1999 [13] to assess the impact of
brucellosis infection in livestock in regions where it is
endemic. This framework is outlined in Fig. 1. It consists
of determining the direct and indirect economic losses
attributable to brucellosis and highlights the wide
breadth of consequences that brucellosis has on the
livelihood of livestock stakeholders in low-resource
communities. Direct effects include those that are
visible, or directly evident to the stakeholder, and those
that are invisible, or that include forgone production
potential [13]. In the case of brucellosis, visible losses
include livestock abortion, reduced milk production, lost
draught power, reduced weight gain from chronic
infections and ill-thrift, premature death or culling of
unproductive stock, veterinary costs associated with
treating clinically ill animals and diminished animal wel-
fare. In endemic areas, Brucella spp. can cause a signifi-
cant reduction in herd productivity that compromises
food security and the livelihood of farmers who depend
on the sale or trade of surplus meat, dairy, and offspring
from their animals. For example, a 6-year brucellosis
control plan implemented on a Mexican dairy farm with
300 cows revealed an increase in average milk produc-
tion by 6 L per day by the conclusion of the study [22].
Multiple studies have also found a correlation between
seropositivity for Brucella spp. and history of abortion
[4]. In Ethiopia, seropositive livestock were found to be
4.7 (cattle) and 6.9 (goats) times more likely to have
aborted in their lifetime when compared to seronegative
animals [23]. This demonstrates that while the decreases
in livestock productivity caused by brucellosis induced
abortion and reduced milk production are multifactorial,
severe production losses can occur as a result. In 2002,
the Food and Agriculture Organization (FAO) released a
study that estimated the effects of eliminating bovine
brucellosis in sub-Saharan Africa. The modelling
estimates predicted that eradicating the disease from this
region would generate between USD $0.497– USD $1
billion in additional income potential for stakeholders
on an annual basis [24]. Furthermore, a study conducted
in India in 2015 attributed a median loss of USD $3.4
billion of revenue to the livestock sector from the
production losses, reduction in fecundity, and premature
deaths of animals infected with brucellosis [25].
Additional visible losses involve the negative effects of
the disease specifically in draught animals. Carpal hygro-
mas are common clinical signs of chronic brucellosis in
cattle [26] and can result in joint pain, inflammation,
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and a reduction in mobility that can be particularly
disabling for them. This has the potential to severely
limit their usefulness as a means of transportation or
draught power and can compromise the income of
farmers or community members who depend on them
for these purposes.
The direct but invisible losses include reduced herd
fertility and the costs associated with changing the herd
structure to compensate for the overall reduction in
productivity and fertility (Fig. 1). In cattle, infertility due
to brucellosis is caused by post-abortion metritis and
retained placentas [27]. Additional invisible losses are
associated with the transmission of Brucella spp. from
infected livestock to wildlife or feral animals that can
then transmit the disease to surrounding herds.
Brucellosis has been successfully eradicated in several
high- income countries through the implementation of
multi-faceted control strategies that include vaccination
and test-and-slaughter of infected livestock [28, 29]. The
World Organisation for Animal Health (OIE) declares
that several countries in Western and Northern Europe,
Canada, Japan, Australia, and New Zealand are free of
Brucella. However, eradication of brucellosis proves
difficult even for developed countries, such as the
United States, because of the ability of some Brucella
spp. to infect multiple species and to reside in feral
populations of ruminants and swine [30, 31]. Once a
reservoir host for brucellosis becomes established in a
region due to this type of transmission event, it is much
more difficult to eradicate and requires a substantial
increase in resources for effective control [32]. For
example, in the United States, USD $3.5 billion was
invested in a brucellosis eradication program that
successfully decreased the prevalence of bovine brucellosis
from 11.5% to 0.0001%. However, despite this investment,
elk and bison in the Greater Yellowstone Ecosystem of
Wyoming, Idaho, and Montana remain reservoirs for the
disease – signifying the difficulties of eradication when
wildlife reservoirs for Brucella spp. exist. Because nomadic
styles of livestock rearing are common in the developing
world, the transmission of brucellosis from infected to
naïve herds of livestock via feral animals or wildlife species
that act as reservoirs is a major concern. A study
conducted in 2015 in the Katavi-Rukwa ecosystem of
Tanzania detected anti-Brucella antibodies in humans,
cattle, goats, and buffalo residing in the region. This is
significant because farmers in this area practice agro-
pastoral livestock rearing and the co-mingling of wildlife
and domestic species is common. In other words, it
suggests that brucellosis has cyclic transmission capabil-
ities that involve humans, livestock, and wildlife species
who live in close proximity to each other [33].
Apart from losses due to disease, which are one source
of economic cost, brucellosis also causes indirect finan-
cial expenditures for disease management and forgone
revenue when a disease is present in a region. Costs for
Fig. 1 Framework to assess the effects of livestock brucellosis in regions where the disease is endemic, adapted from Rushton et al., 1999
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veterinary services, vaccination, diagnostics, farmer
indemnification, and a system for animal identification
and maintenance of surveillance records are incurred
when a disease management plan is implemented on a
regional or national level. However, before a control plan
can be pursued, a stable veterinary infrastructure and
system for animal identification must be in place. While
the resources allocated to developing this infrastructure
can be greater than the capital of product preserved
after an effective Brucella control plan is established, it
is important to note that this is essential for decreasing
the incidence of all livestock and zoonotic diseases.
Therefore, this cost can be distributed and analyzed
alongside all diseases that affect livestock productivity in
a region of interest.
Furthermore, forgone revenue related to brucellosis
includes trade restrictions from areas endemic with B.
melitensis, B. abortus, and B. suis. These Brucella spp.
are listed as notifiable diseases by the OIE – a list made
in compliance with the Sanitary and Phytosanitary
Agreement of the World Trade Organization that helps
to guide policy development concerning the inter-
national trade of products contaminated with specific
biological agents [34].
Overview of brucellosis impact in humans where it is
endemic
We used the framework proposed by Jo (2014) [14] to
assess the impact of endemic brucellosis in human
populations. A thorough compilation of the intangible,
direct and indirect costs as presented in the literature is
discussed as they relate to the cost of illness (COI), or
burden of disease, when brucellosis is present in a
population (Fig. 2). According to the framework, intan-
gible costs include those that diminish a patient’s quality
of life but that cannot be easily standardized between
individuals and therefore typically lack a predictable
monetary value. Direct costs include healthcare costs, or
medical expenditures for the diagnosis, treatment and
management of clinically-ill patients, and non-healthcare
costs, or those that provide a patient with access to care
[14]. Indirect costs include those associated with the
morbidity and mortality of a disease that specifically affect
the patient and society in which the patient lives [14].
In regions where brucellosis is endemic, intangible
costs contributing to the overall burden of disease
include physical pain and emotional suffering. In about
half of all cases, the disease presents as an acute febrile
condition with patients commonly reporting joint and
back pain, fatigue, headaches, and a loss of appetite [35].
However, infection can cause complications in any organ
system, and a delayed onset of symptoms and chronic
form of the disease are common [35]. Emotional suffer-
ing results directly from the decrease in quality of life of
persons experiencing clinical symptoms and from the
effects that the disease has on the livelihood of small
scale livestock stakeholders. In general, farmers with
small holdings of livestock, the typical production
scheme in low-income regions, suffer from increased
stress and a lack of access to support or mental health
services [36]. In 2016, a study conducted in India
revealed that farmers were more likely to commit suicide
because of socioeconomic factors like indebtedness
rather than mental disease [37]. Extrapolate these
findings to a disease like brucellosis, which has consider-
able negative implications on livestock productivity, and
it is evident that farmers’ feelings of grief, hopelessness,
depression, and suicide are likely amplified in regions
where the disease is perpetuated.
Direct effects of brucellosis in human populations
include the associated healthcare and non-healthcare
costs of the disease. Healthcare costs include the
expenses related to laboratory diagnostics, physician
services, hospitalization, treatment, and medications for
the clinically-ill.
Depending on the existing healthcare system where
the patient lives, the responsibility for paying these costs
can fall on the patient, patient’s family, insurer, hospital,
taxpayers, or government. Human brucellosis is a
disease that results in significantly higher healthcare
costs compared to the average patient seeking medical
care [38]. A study conducted in southern Israel revealed
that healthcare utilization costs for brucellosis patients
was USD $57 (p < 0.05) greater before diagnosis and
USD $947 (p < 0.001) greater one year post diagnosis
when compared to non-brucellosis cases that were
matched by age, sex, hospital, and primary care
physician [38]. The higher costs of patients post diagno-
sis stem from higher utilization of medications, spinal/
skeletal diagnostic procedures, emergency room visits,
and laboratory tests [38].
Non-healthcare costs include expenses related to a
patient’s access to care and the prevention of disease.
Transport to and from medical facilities, housing accom-
modations while care is being received, and a loss of
work days or leisure time when seeking medical
attention can amount to significant expenses that the
patient or their families are responsible for paying out-
of-pocket. It should also be noted that while individuals
in low-resource settings have an increased prevalence of
health complications and shorter life expectancy, access
to health services in these areas is significantly lacking
[39]. Thus, it is evident that the costs for acquiring
medical care are amplified for persons affected by
brucellosis because it is a disease predominantly
affecting the poor. Preventative measures to control
brucellosis in the human population are other important
non-healthcare costs to consider. Risk factors for Brucella
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infection include occupations that involve contact with
livestock or their products and the human consumption
of raw milk products such as ghee and un-boiled milk
[40]. The risk factors of brucellosis may vary from country
to country and region to region, but most risk factors are
similar. Consumption of unpasteurized milk and milk
products plays a very important role in the transmission
of this infection from animals to humans, in addition to
direct contact with infected animals and their secretions.
The best way to control this ubiquitous infection is
through the One Health approach which involves hu-
man health, animal health, and environmental health
[41]. The dissemination of educational information
about disease prevention to regions where Brucella is
endemic is therefore essential for controlling the
disease [40]. Furthermore, because infected animals
and their products are the primary source of human
infections, control of brucellosis in livestock and the
development of an effective veterinary infrastructure
is an important step to mitigating the disease in
humans [42].
In regions where brucellosis is endemic, indirect
effects include adverse obstetric events in pregnant
women, delays in treatment due to misdiagnosis, lost
leisure time and productive years due to illness or
premature death, and a loss of work days for both the
patient and caregiver. Furthermore, misdiagnosis is
common when patients present with brucellosis because
the symptoms can be vague, non-specific and mimic
other diseases that persist in low-resource settings such
as malaria and typhoid [43]. This misdiagnosis often
leads to a delay in treatment and can result in long term
complications from the disease [44], as well as create
discrepancies between the reported and actual number
of human cases in a region. Pregnant women infected
with brucellosis can develop devastating complications
such as preterm labor and delivery, congenital
malformations, low birth weight, abortion, and fetal,
neonatal and maternal death [45]. The severity of clinical
signs if a woman becomes infected does not correlate to
the likelihood that she will suffer a miscarriage [46]. In
other words, she may miscarry or suffer other severe
Fig. 2 Framework to assess the effects of human brucellosis in regions where the disease is endemic, adapted from Jo, 2014
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complications without ever recognizing a need to seek
treatment until after it is too late for medical interven-
tion to be effective.
The population effect of brucellosis in regions where
the disease is endemic includes a decrease in food
security, a reduction in the size of the workforce which
is physically able, and the propagation of gender inequal-
ity. In these settings, the reduction in milk production
and fertility caused by Brucella infections in livestock
drastically compromises food security and increases
malnutrition in already severely nutrition poor commu-
nities. For example, in 2002 the FAO estimated that an
average of 371,000 tons of additional meat and 616,000
tons of additional milk would have been generated
during that year if brucellosis was eradicated in sub-
Saharan Africa alone [24]. This is particularly important
because it is well accepted that adequate nutrition is
essential in early childhood for cognitive development
and that the propagation of malnutrition in a population
can have serious consequences for society as a whole
[47]. It is also important to note that in some cases,
increased livestock production allows women to increase
their control over personal income and assets, which is
an important mechanism to reduce gender inequalities
in patriarchal societies [48]. Controlling brucellosis in
livestock populations increases production and in turn
aids women, the primary livestock caretakers in most low-
income communities [48], to overcome social oppression
and dependency.
Interdisciplinary call to action
One of the most effective means to reduce the burden of
any disease is to reduce its prevalence in regions where it
is endemic. Vaccine campaigns, community outreach and
education, and conducting accurate disease surveillance
estimates are the cornerstones of these efforts. However,
there are currently no Brucella vaccines available for use
in humans that are considered to be safe and effective
[49]. Furthermore, the vaccines available for use in
animals do not allow for differentiation between naturally
infected and vaccinated animals on serological diagnostic
tests [50], a distinction that is imperative for assessing the
success of any vaccination program and for estimating
true disease prevalence after vaccines have been adminis-
tered in a respective region. Hence, research funding that
is focused on developing improved vaccines and diagnos-
tic tools for brucellosis is an essential first step of the ever-
evolving strategy to solve the Brucella puzzle.
The implications of brucellosis that are synthesized in
this paper suggest that to reduce or eradicate it, an inter-
disciplinary, or “Global One Health”, approach is essential.
One Health encompasses the methodology that human,
animal and environmental health are closely intertwined,
and that improvement in one of these areas is contingent
on the interdependence of all three. Thus, collaboration
between professionals across multiple disciplines and
sectors is imperative to reaching solutions that lead to the
mitigation of infectious diseases such as brucellosis
ultimately adding economic value. In 2003, an economic
model for brucellosis was simulated in Mongolia to assess
the success and financial return of livestock vaccination
on the incidence of the disease in humans. The study
demonstrated that an investment of USD $8.3 million for
mass vaccination of cattle and small ruminants using
commercially available vaccines would result in a
USD $26.6 million return (or net present value of
USD $18.3 million).
This is an example of increased livestock production
and profitability, while at the same time reducing human
healthcare costs, income loss, and coping costs in the
target region [51]. This demonstrates the importance of
implementing a holistic and multi-disciplinary approach
to the mitigation of brucellosis by incorporating
strategies that break the cycle of transmission from
animals to humans and can be applied to other zoonotic
diseases. Similarly, in 2009, the United States Agency for
International Development (USAID) created an initiative
called PREDICT. PREDICT successfully began a move-
ment of collaboration between government ministries,
scientific institutions, local organizations and stake-
holders to promote human and animal health, effective
resource management, and economic development in
twenty countries [52]. With the success of the Mongolia
and PREDICT models in mind, and considering the
unique pathology of brucellosis and its far-reaching
socioeconomic effects in the resource-poor countries of
the world where livestock of small holder farmers is
their livelihood and “bank account,” it is evident that
partnerships between veterinary, medical, environmental,
economic, cultural, policy, and societal experts are
essential to reducing the burden of this disease across
the globe.
Conclusions
Brucellosis is an endemic zoonotic disease in low, middle,
and high-income countries that causes devastating losses
to the livestock industry including small-scale livestock
holders. It places significant burdens on human healthcare
systems and limits the economic potential of individuals,
communities, and nations where such development is
especially important to diminish the prevalence of poverty.
The implementation of public policy focused on mitigat-
ing the socioeconomic effects of brucellosis in human and
animal populations is desperately needed. The interdiscip-
linary “One Health” nature of the effects that brucellosis
has indicate that collaboration of veterinary, medical,
public health, cultural, economic and social experts is
needed to effect a change in disease burden.
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Important topics for future studies include generating
assessments about the impact of brucellosis as it relates
to the exponential growth of the human population and
the increasing intensification of livestock production
systems worldwide. This, coupled with projections that
address the cost-effectiveness of mitigation measures,
will be vitally important for policy-makers to make
informed decisions to manage this disease. While there
are still many questions to be answered regarding the
true burden of brucellosis worldwide, control and
mitigation in regions where it is endemic will help to
improve food security, household income, and human
and animal health in low-resource communities. Allocat-
ing resources towards the research and development of
improved Brucella vaccines and diagnostic tools is an
important facet of addressing the problem. It is essential
to engage community leaders in developing tools and
resources which are effective in building outreach and
education campaigns at the local level. It is especially
critical to apply initiatives that teach people how to
protect themselves, their families, and their communities
from the disease through sustainable improvements and
education. Some possible focus areas are sanitation and
hygiene, food safety, biosecurity, and livestock manage-
ment techniques that are culturally and financially
feasible given the location of interest. This approach will
inevitably lead to healthier populations of humans and
animals at the community level and result in a ripple
effect that builds more stable economies and improves
the health and productivity of multiple species on a
global scale.
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